Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 11 | 11 | 11 | 11 | 10 |
| Accounts receivable | -6 | -22 | 16 | -26 | 30 |
| Accounts payable and accrued liabilities | N/A | 115 | 63 | -188 | 328 |
| Other Working Capital | -64 | 151 | 357 | -227 | 149 |
| Other Operating Activity | -4,169 | -3,112 | -2,463 | -1,680 | -1,804 |
| Operating Cash Flow | $-4,227 | $-2,856 | $-2,016 | $-2,110 | $-1,287 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | 0 | N/A | N/A | 0 |
| Other Investing Activity | 0 | 0 | -3 | -42 | 0 |
| Investing Cash Flow | $-5 | $0 | $-3 | $-42 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 11,521 | 2,343 | N/A | N/A |
| Other Financing Activity | 128 | 67 | 465 | 4,516 | 701 |
| Financing Cash Flow | $128 | $11,588 | $2,808 | $4,516 | $701 |
| Exchange Rate Effect | 4 | -52 | 100 | 9 | -26 |
| Beginning Cash Position | 16,929 | 8,249 | 7,360 | 4,987 | 5,599 |
| End Cash Position | 12,828 | 16,929 | 8,249 | 7,360 | 4,987 |
| Net Cash Flow | $-4,104 | $8,731 | $790 | $2,364 | $-586 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,227 | -2,856 | -2,016 | -2,110 | -1,287 |
| Capital Expenditure | -5 | N/A | -3 | N/A | N/A |
| Free Cash Flow | -4,233 | -2,856 | -2,018 | -2,110 | -1,287 |